<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Group I Epstein-Barr virus (EBV)-positive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells display a surface phenotype characteristic of germinal centre B cells and readily undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in response to a variety of stimuli, including serum deprivation </plain></SENT>
<SENT sid="1" pm="."><plain>Activation of EBV latent gene expression has been shown to increase the survival of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells by blocking programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate the nature of this protection, we assessed the function of the EBV latent EBNA-4 gene in a group I <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line, dG75 </plain></SENT>
<SENT sid="3" pm="."><plain>Group I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells induced to undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in response to serum starvation were protected in the presence of EBNA-4 protein </plain></SENT>
<SENT sid="4" pm="."><plain>A possible factor underlying this EBNA-4-associated survival was increased expression of the oncoprotein bcl-2, a known repressor of cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Together these data suggest that EBNA-4 plays an important role in the regulation of programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
</text></document>